Is solitary plasmacytoma a type of multiple myeloma?
Solitary plasmacytoma is a rare disorder that is similar to multiple myeloma. People with solitary plasmacytoma do not have myeloma cells in the bone marrow or throughout the body. Instead, they have a tumor composed of plasma cells that is restricted to a single area of the body.
Can you have plasmacytoma and multiple myeloma?
Multiple myeloma is not confined to a specific bone or location within a bone. It tends to involve the entire skeleton. When only one lesion is found it is called a plasmacytoma. Most doctors believe that plasmacytoma is simply an early, isolated form of multiple myeloma.
What type of cancer is solitary plasmacytoma?
Solitary plasmacytoma (SP) is an early-stage plasma cell malignancy that is in between monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) along the spectrum of plasma cell disorders.
What is life expectancy of plasmacytoma?
Plasmacytoma life expectancy. The median survival time for plasmacytoma averages 10 years 38).
How do you treat solitary plasmacytoma?
The treatment used most commonly for both types of plasmacytoma is radiotherapy. This is possible because by definition, “solitary plasmacytomas” are localised. Radiotherapy involves focusing radiation (similar to x-rays) on the plasmacytoma to kill the abnormal cells.
Is plasmacytoma serious?
Plasmacytoma is a very rare form of blood cancer that’s similar to multiple myeloma. There are two types of plasmacytomas — solitary plasmacytoma of bone (SPB) and extramedullary plasmacytoma (EMP).
Is plasmacytoma considered cancer?
A plasmacytoma is a type of abnormal plasma cell growth that is cancerous. Rather than many tumors in different locations as in multiple myeloma, there is only one tumor, hence the name solitary plasmacytoma. A solitary plasmacytoma often develops in a bone.
Can you survive plasmacytoma?
Patients with skeletal plasmacytoma had an overall survival of 57% at 5 years and 37% at 10 years. Females have a significantly lower 5 and 10 year survival than males (5 year survival 54% v/s 59% for males (p-value = 0.008).
Is plasmacytoma fatal?
Most cases of SPB progress to multiple myeloma within 2–4 years of diagnosis, but the overall median survival for SPB is 7–12 years. 30–50% of extramedullary plasmacytoma cases progress to multiple myeloma with a median time of 1.5–2.5 years.
What is solitary plasmacytoma of bone?
Solitary plasmacytoma of bone (SPB, also called osseous plasmacytoma) is a localized tumor in the bone comprised of a single clone of plasma cells in the absence of other features of MM (ie, anemia, hypercalcemia, renal insufficiency, or multiple lytic bone lesions) [6,7].